Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 09/18/2026 | CALL | $2.50 | 1,068 | +75 | +7.55% |
| 04/17/2026 | CALL | $2.50 | 207 | +1 | +0.49% |
| 04/17/2026 | CALL | $5.00 | 10 | 0 | |
| 04/17/2026 | CALL | $7.50 | 160 | 0 | |
| 04/17/2026 | PUT | $2.50 | 5 | 0 | |
| 04/17/2026 | PUT | $5.00 | 0 | 0 | |
| 06/18/2026 | PUT | $7.50 | 0 | 0 | |
| 09/18/2026 | CALL | $5.00 | 217 | 0 | |
| 09/18/2026 | CALL | $7.50 | 1 | 0 | |
| 09/18/2026 | PUT | $2.50 | 21 | 0 | |
| 09/18/2026 | PUT | $5.00 | 0 | 0 | |
| 09/18/2026 | PUT | $7.50 | 1 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 1.10% | 951.94k | 1.19M |
| Delaware Group Equity Fds IV-Delaware Healthcare Fund | 0.98% | 852.94k | 1.07M |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 0.66% | 573.94k | 717.42k |
| PFS Funds-Taylor Frigon Core Growth Fund | 0.32% | 279.21k | 349.01k |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 0.32% | 277.24k | 346.55k |
| DFA Continental Small Company Series | 0.13% | 113.94k | 142.43k |
| SPDR Portfolio Developed World ex-US ETF | 0.10% | 87.69k | 109.61k |
| Parametric International Equity Fund | 0.08% | 65k | 81.25k |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.07% | 61.56k | 76.95k |
| Vanguard Intl Equity Index - Total World Stock Index Fd | 0.04% | 36.69k | 45.87k |
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
07/02 09:22 am
Zacks Investment Research
Read moreFDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease
07/01 10:31 am
Zacks Investment Research
Read moreApellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
07/01 08:44 am
Zacks Investment Research
Read morePTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
07/01 08:00 am
Zacks Investment Research
Read moreCogent (COGT) Up on SUMMIT Study Update Post Positive FDA Meeting
06/28 09:18 am
Zacks Investment Research
Read moreMerck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
06/28 07:28 am
Zacks Investment Research
Read moreNovo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal
06/27 10:22 am
Zacks Investment Research
Read moreCASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
06/27 09:42 am
Zacks Investment Research
Read moreBayer's (BAYRY) AskBio Advances Parkinson Disease Study
06/26 01:58 pm
Zacks Investment Research
Read moreImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why
06/26 09:41 am
Zacks Investment Research
Read moreAlnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
06/25 08:59 am
Zacks Investment Research
Read moreShould You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
06/20 08:23 am
Zacks Investment Research
Read moreDay One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up
06/19 10:29 am
Zacks Investment Research
Read moreIntra-Cellular (ITCI) Up as Second Depression Study Meets Goals
06/19 10:27 am
Zacks Investment Research
Read moreAerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
06/18 09:21 am
Zacks Investment Research
Read moreApellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
06/11 09:48 am
Zacks Investment Research
Read moreChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag
06/10 09:45 am
Zacks Investment Research
Read moreRepare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
06/06 09:59 am
Zacks Investment Research
Read moreAnnexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals
06/05 10:57 am
Zacks Investment Research
Read moreIntellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data
06/04 11:21 am
Zacks Investment Research
Read moreCompugen (CGEN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
06/04 09:55 am
Zacks Investment Research
Read moreCompugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
05/20 08:10 am
Zacks Investment Research
Read moreAre You Looking for a Top Momentum Pick? Why Compugen (CGEN) is a Great Choice
03/12 12:00 pm
Zacks Investment Research
Read moreBOX Gears Up to Report Q4 Earnings: Here's What to Expect
03/04 11:55 am
Zacks Investment Research
Read moreWill Petrobras (PBR) Report Q4 Earnings Beat on Output Gains?
03/04 09:42 am
Zacks Investment Research
Read moreIs a Surprise Coming for Compugen (CGEN) This Earnings Season?
02/29 09:58 am
Zacks Investment Research
Read morePuma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
02/27 12:51 pm
Zacks Investment Research
Read moreBaidu (BIDU) to Report Q4 Earnings: What's in the Offing?
02/27 11:29 am
Zacks Investment Research
Read moreVipshop (VIPS) to Post Q4 Earnings: What's in the Offing?
02/27 11:25 am
Zacks Investment Research
Read moreACM Research (ACMR) to Report Q4 Earnings: What's in Store?
02/27 09:57 am
Zacks Investment Research
Read moreWhat to Look for in Crescent Point's (CPG) Q4 Earnings?
02/27 08:13 am
Zacks Investment Research
Read moreAgilent Technologies (A) to Post Q1 Earnings: What's in Store?
02/26 01:23 pm
Zacks Investment Research
Read moreWhat's in Store for Qurate Retail (QRTEA) in Q4 Earnings?
02/26 11:17 am
Zacks Investment Research
Read moreGinkgo (DNA) to Report Q4 Earnings: What's in the Cards?
02/26 10:18 am
Zacks Investment Research
Read moreEton Pharma (ETON) to Report Q4 Earnings: What's in the Cards?
02/26 09:19 am
Zacks Investment Research
Read moreCompugen (CGEN) is a Great Momentum Stock: Should You Buy?
02/21 01:00 pm
Zacks Investment Research
Read moreBiotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
12/21 12:39 pm
Zacks Investment Research
Read moreGilead (GILD), Compugen Collaborate for Immunotherapy Program
12/20 11:33 am
Zacks Investment Research
Read moreCompugen's stock rockets on deal with Gilead for anti-tumor drug
12/19 11:52 am
MarketWatch
Read moreUS Stocks Higher; Accenture Issues Weak Sales Outlook
12/19 10:42 am
Benzinga
Read moreIs Compugen (CGEN) Outperforming Other Medical Stocks This Year?
12/05 10:40 am
Zacks Investment Research
Read moreThese Israeli pharmaceutical stocks are down in the wake of Hamas attack
10/09 09:51 am
MarketWatch
Read moreKaruna (KRTX) Submits NDA Filing to FDA for Schizophrenia Drug
09/29 12:32 pm
Zacks Investment Research
Read moreIs Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?
09/14 09:40 am
Zacks Investment Research
Read moreHas Compugen (CGEN) Outpaced Other Medical Stocks This Year?
08/29 09:40 am
Zacks Investment Research
Read more5 Analysts Have This to Say About Compugen
08/07 01:00 pm
Benzinga
Read moreExpert Ratings for Compugen
05/26 01:00 pm
Benzinga
Read more